Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
Outcomes in patients with refractory/relapsed CNS lymphoma treated in complete remission: autologous transplantation vs. CAR-T therapy | Researchclopedia